Aqemia

Series-A
aqemia.com Biotech & Healthcare
Total Funding $38M
Latest Round $38M Series-A
Last Announced Dec 10, 2024
Investors Undisclosed
Decision Makers 3 Verified

About Aqemia

AQEMIA is reinventing drug discovery with physics-based AI, enabling faster invention of new medicines for unmet needs (including oncology).

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Undisclosed
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website aqemia.com
Domain Registered Date Feb 15, 2019

Social & Network Presence

X / Twitter Profile @aqemia (452 followers) Created on Sep 2020
LinkedIn Corporate Not linked

Company Milestones & Timeline

4 Events
  1. Capital Raise

    Raised $38,000,000 · Venture Round

    fundraisingfox.com

  2. Capital Raise

    Series-A announced

    fundraisingfox.com

  3. Milestone

    X account created (@aqemia)

    452 followers

  4. Milestone

    Website domain registered

    aqemia.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Aqemia.

Funding History

2 Rounds
Venture Round · Dec 10, 2024
Series-A · Feb 2, 2024

Founders & Leadership

1

Maximilien Levesque

Co-founder and CEO

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts